Alaunos Therapeutics Inc (STU:WEK)
€ 1.66 0 (-4.82%) Market Cap: 338.23 Mil Enterprise Value: 276.94 Mil PE Ratio: 0 PB Ratio: 1.04 GF Score: 54/100

ZIOPHARM Oncology Inc Annual Shareholders Meeting Transcript

Jun 29, 2020 / 01:00PM GMT
Release Date Price: €2.76 (-12.66%)
Operator

Good day, everyone, and welcome to the ZIOPHARM Oncology, Inc. Annual Meeting of Stockholders.

At this time, I'd like to turn the conference call over to Laurence Cooper. Sir, please go ahead.

Laurence James Neil Cooper
ZIOPHARM Oncology, Inc. - CEO & Director

Thank you. Good morning. I am Dr. Laurence Cooper, President, CEO and Director of ZIOPHARM Oncology, Inc. And it is my pleasure to welcome you to the company's 2020 Annual Meeting of Stockholders, which, due to public health concerns regarding the ongoing coronavirus pandemic, is being held virtually and exclusively online by a live audio-only webcast.

This meeting was called to be held at 9 am Eastern Time today, and it being 9 am now, I will officially call this meeting to order by way of introductions. Joining today's webcast are members of the management, including Sath Shukla, EVP, Chief Financial Officer; and Robert Hadfield, EVP, General Counsel. In addition, the other members of the Board of Directors attending this webcast today are Scott Tarriff, Dr. Christopher Bowden,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot